Who is sponsoring NCT03887234?

NCT03887234 is sponsored by University of Turku.

What drugs are being tested in NCT03887234?

Interventions in NCT03887234: Coracoclavicular ligament reconstruction.

What condition does NCT03887234 study?

NCT03887234 studies AC Joint Dislocation.

Is NCT03887234 still recruiting?

NCT03887234 is currently completed. Last updated 27 December 2022.

Last reviewed 2022-12-27 · How we verify

NCT03887234

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Arthroscopic Coracoclavicular Ligament Reconstruction Comparing Two Techniques

Completed NA Last updated 27 December 2022

What this trial tests

NA trial testing Coracoclavicular ligament reconstruction in AC Joint Dislocation in 27 participants. Completed in 19 October 2022.

Timeline

1 September 2018

Primary endpoint
19 October 2020

19 October 2022

Quick facts

Lead sponsor	University of Turku
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	27
Start date	1 September 2018
Primary completion	19 October 2020
Estimated completion	19 October 2022
Sites	1 location across Finland

Drugs / interventions tested

Coracoclavicular ligament reconstruction

Conditions studied

AC Joint Dislocation — all drugs for AC Joint Dislocation →

Sponsor

University of Turku

Who can join

Adults 16 to 70, any sex, with AC Joint Dislocation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study follows early wound healing using knot hiding titanium implants in coracoclavicular ligament reconstruction. A further aim is to compare two techniques where the semitendinosus tendon graft either runs through the coracoid drill hole or goes around the coracoid.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Turku trials

Trials by the same sponsor.

NCT07084389 — A Financial Social Work Intervention for Families With Complex Financial Difficulties (FinSoc) · NA · recruiting
NCT06886581 — Online Training Course to Improve Evidence-based Leadership · NA · recruiting
NCT06856408 — Power of Growth - Digitally Assisted Intervention for the Early Childhood Educators' Self-efficacy Teamwork and Children · NA · recruiting
NCT06627868 — Nicotinamide Adenine Dinucleotide (NAD+) Metabolism in Human Brown Adipose Tissue · NA · recruiting
NCT06284772 — FINRISK 2002 Re-examination · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03887234 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Turku
Last refreshed: 27 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03887234.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing